|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| G01N2800/32 | (2013.01) | ||
| G01N2800/50 | (2013.01) | ||
| G01N 33/6893 | (2013.01) |
| (11) | Number of the document | 3517964 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18210390.3 |
| Date of filing the European patent application | 2015-03-20 | |
| (97) | Date of publication of the European application | 2019-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 14305406 | 2014-03-21 | EP | |
| 14306528 | 2014-09-30 | EP |
| (72) |
HESS, Sibylle , DE
GERSTEIN, Hertzel , CA
PARE, Guillaume , CA
MCQUEEN, Matthew , CA
|
| (73) |
Sanofi-Aventis Deutschland GmbH ,
Brüningstrasse 50, 65929 Frankfurt,
DE
McMaster University , 1280 Main Street West, Hamilton, Ontario L8S 4L8, CA |
| (54) | NEW MARKERS FOR THE ASSESSMENT OF THE RISK FOR DEVELOPMENT OF A CARDIOVASCULAR DISORDER |
| NEW MARKERS FOR THE ASSESSMENT OF THE RISK FOR DEVELOPMENT OF A CARDIOVASCULAR DISORDER |